EMA has just released, for consultation, a new concept paper on the revision of the guidelines on the development of new medicinal products for the treatment of Crohn’s disease. Consultation ends on 15 February 2013.

 

Summary

 

The proposed guideline will replace the guideline on the development of new medicinal products for the treatment of Crohn’s disease (CPMP/EWP/2284/99 Rev. 1).

 

Posted on the EMA website on 14 Nov 2012